
| Open | 92.71 |
| Previous Close | 92.71 |
| Volume | 7,993.00 |
| Value (Lacs) | 7.38 |
| VWAP | 92.72 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 114 |
| High | 95.79 |
| Low | 90.36 |
| UC Limit | 111.25 |
| LC Limit | 74.17 |
| 52 Week High | 206.12 |
| 52 Week Low | 81.01 |
| Face Value | 10.00 |
| All Time High | 348.45 |
| All Time Low | 13.10 |
| 20D Avg Volume | 20,942 |
| 20D Avg Delivery(%) | 49.92 |
| Book Value Per Share | -- |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | 0.00 (-47.00% YoY) |
| TTM PE See historical trend | -- (Low PE) |
| P/B See historical trend | 0.00 |
| Sector PE | 39.47 |
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
5 out of 7 years Par Drugs & Chemicals has given negative returns in January.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| January | 5.69% (2023) | 5.69% | -16.10% (2020) | -9.68% | -7.12% |
Stocks to Watch Today: Urban Company, Jindal Steel, PNC Infratech, Akzo Nobel, RailTel, Coal India, Tech Mahindra, BEL, DevX, NLC India in focus on 17 September Sep 17 2025 01:55 AM
Sebi bars API maker Par Drugs from slump sale, orders independent valuation and fairness opinion Sep 15 2025 07:10 PM
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y Aug 22 2025 01:15 PM
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y May 12 2025 11:34 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 62256 | Price 192.03 | % Traded 0.51 |
| Qty 7026 | Price 191.4 | % Traded 0.06 |
| Qty 185653 | Price 238.32 | % Traded 1.51 |
| Qty 178799 | Price 238.91 | % Traded 1.46 |
| Qty 124353 | Price 236.91 | % Traded 1.01 |
| Qty 124353 | Price 236.89 | % Traded 1.01 |
| Qty 109695 | Price 238.32 | % Traded 0.89 |
| Qty 109258 | Price 238.31 | % Traded 0.89 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|